Sol-Gel Technologies - 7 Year Stock Price History | SLGL

Historical daily share price chart and data for Sol-Gel Technologies since 2018 adjusted for splits and dividends. The latest closing stock price for Sol-Gel Technologies as of June 12, 2025 is 6.90.
  • The all-time high Sol-Gel Technologies stock closing price was 171.50 on December 31, 2019.
  • The Sol-Gel Technologies 52-week high stock price is 16.50, which is 139.1% above the current share price.
  • The Sol-Gel Technologies 52-week low stock price is 3.34, which is 51.6% below the current share price.
  • The average Sol-Gel Technologies stock price for the last 52 weeks is 6.75.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Sol-Gel Technologies Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 7.0469 10.1500 14.0000 4.1000 6.9000 -25.81%
2024 8.0640 12.2010 16.5000 3.6600 9.3010 -15.83%
2023 30.2998 47.3000 53.2000 9.2020 11.0500 -75.77%
2022 59.5025 78.2000 82.1000 41.0000 45.5990 -38.38%
2021 102.3413 99.3000 154.9000 65.7000 74.0000 -24.41%
2020 88.3865 157.5000 157.5000 58.8000 97.9000 -42.92%
2019 80.4279 63.5000 171.5000 57.1000 171.5000 184.88%
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.019B $0.012B
Sol-Gel Technologies Ltd.is a clinical-stage dermatology company. It focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. Its product candidates include VERED for the treatment of papulopustular rosacea, TWIN and SIRS-T for the treatment of acne vulgaris, which are in its clinical stage. Sol-Gel Technologies Ltd.is based in Israel.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.865B 7.10
Dr Reddy's Laboratories (RDY) India $13.298B 24.14
BridgeBio Pharma (BBIO) United States $7.415B 0.00
Bausch Health Cos (BHC) Canada $1.973B 1.42
Supernus Pharmaceuticals (SUPN) United States $1.856B 15.07
Amphastar Pharmaceuticals (AMPH) United States $1.228B 8.24
Taysha Gene Therapies (TSHA) United States $0.573B 0.00
Personalis (PSNL) United States $0.518B 0.00
Assembly Biosciences (ASMB) United States $0.130B 0.00
Evoke Pharma (EVOK) United States $0.004B 0.00
Teligent (TLGT) United States $0.000B 0.00